» Articles » PMID: 28842527

Mechanisms Contributing to Cardiac Remodelling

Overview
Journal Clin Sci (Lond)
Date 2017 Aug 27
PMID 28842527
Citations 80
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiac remodelling is classified as physiological (in response to growth, exercise and pregnancy) or pathological (in response to inflammation, ischaemia, ischaemia/reperfusion (I/R) injury, biomechanical stress, excess neurohormonal activation and excess afterload). Physiological remodelling of the heart is characterized by a fine-tuned and orchestrated process of beneficial adaptations. Pathological cardiac remodelling is the process of structural and functional changes in the left ventricle (LV) in response to internal or external cardiovascular damage or influence by pathogenic risk factors, and is a precursor of clinical heart failure (HF). Pathological remodelling is associated with fibrosis, inflammation and cellular dysfunction (e.g. abnormal cardiomyocyte/non-cardiomyocyte interactions, oxidative stress, endoplasmic reticulum (ER) stress, autophagy alterations, impairment of metabolism and signalling pathways), leading to HF. This review describes the key molecular and cellular responses involved in pathological cardiac remodelling.

Citing Articles

Baicalin Prevents Chronic β-AR Agonist-Induced Heart Failure via Preventing Oxidative Stress and Overactivation of the NADPH Oxidase NOX2.

Ge Y, Ma E, Guo X, Wang Q, Zhu W, Ren D J Cell Mol Med. 2025; 29(4):e70388.

PMID: 39988987 PMC: 11847971. DOI: 10.1111/jcmm.70388.


HACE1 protects against myocardial ischemia-reperfusion injury via inhibition of mitochondrial fission in mice.

Liu B, Zheng J, Tang Z, Gao L, Wang M, Sun Y BMC Cardiovasc Disord. 2025; 25(1):77.

PMID: 39901081 PMC: 11792395. DOI: 10.1186/s12872-024-04445-2.


Explainable AI associates ECG aging effects with increased cardiovascular risk in a longitudinal population study.

Hempel P, Ribeiro A, Vollmer M, Bender T, Dorr M, Krefting D NPJ Digit Med. 2025; 8(1):25.

PMID: 39806125 PMC: 11730300. DOI: 10.1038/s41746-024-01428-7.


4-Hydroxychalcone attenuates AngII-induced cardiac remodeling and dysfunction via regulating PI3K/AKT pathway.

Han X, Zhu Q, Li Z, He J, Sun Y, Zhong Q Hypertens Res. 2024; 48(3):1054-1067.

PMID: 39715792 PMC: 11879844. DOI: 10.1038/s41440-024-02068-w.


A multi-omics approach identifies the key role of disorders of sphingolipid metabolism in Ang II-induced hypertensive cardiomyopathy myocardial remodeling.

Qu Y, Ma D, Wu T, Wang H, Tian Z, Liu X Sci Rep. 2024; 14(1):30379.

PMID: 39638825 PMC: 11621778. DOI: 10.1038/s41598-024-81611-8.